Incoming orders at Drägerwerk rose by 7.5 percent in the third quarter. In terms of sales, there is an increase of around 30 percent to 862.5 million euros. The EBIT increased from 9.3 million euros to 127.0 million euros.
For the year as a whole, Drägerwerk is anticipating an increase in sales of 14 percent to 22 percent, and the EBIT margin should be 7 to 11 percent. The middle to upper end of the range is more likely. Sales and earnings in 2021 should be below the values of 2020.
The analysts from Independent Research expect earnings per share of EUR 8.09 (previously: EUR 5.87) for Drägerwerk in 2020. The forecast for 2021 drops from EUR 4.19 to EUR 4.12.
The experts continue to give a hold recommendation for Drägerwerk shares. The price target for the preference shares will be increased from EUR 78.00 to EUR 79.00.
The shares of Drägerwerk lose 1.2 percent to 72.60 euros.
At a glance – chart and news: Drägerwerk Vz.